n n n n
And Answers
n n
Question 1 n 0/1
A Lower
n
.
B Media
n
. n n
CHighe
n
. r n
D Absen
n
. t n
Question 2 1/1 n n
A A speculum exam
n n n n n
.
B A bimanual exam
n nn n n
.
C A pap smear
n nn nn
.
DA transvaginal
n
nn n
. ultrasound
Question 3 n 1/1
A Challenging behaviors in others that promote
n
n n n n n n n n n
violence
.
B Engaging in healthy professional and personal
n
n n n n n n n n n
. relationships
C Learning to identify risk factors for sexually abusive
n
. behaviors
D B and C n n n
.
E A, B, and C
n n n n n n n
.
Question 4 n 1/1
,NRNP6552WomenshealthmidtermCorrectlyVerifiedQuestions n n n n
And Answers
n n
A 6-12 n
. months
B 6-18
n
. months
C 12-24 n
. months
D3-5 years
n n
.
Question 5 n 1/1
Barriers nc n n i for
c nc n n ci providers nc n n i related
c ito
nc n n c nc n n c i intimate i partner
nc n n c nc n n i violence
c nc n n iscreening nc n n i include:
c
A Discomfort with the topic
n n n n n
.
B Having too much power that might be
n
n n n n n n n n n n
. intimidating
C Time constraints
n n
.
D A and C n n n
.
E A, B, and C
n n n n n n n
.
Question 6 n 1/1
Hirsutism i is i defined i as: nc n n c nc n n c nc n n c
A Excessive terminal hair loss in
n
n n n n n n
. women
B Excessive nail growth in women
n n n n n n
.
C Brittle nail growth in women
n n n n n n
.
D Excessive terminal hair growth in
n
n n n n
. women
Question 7 n 0/1
A i pharmacologic i treatment
nc n n c nc n n n c ncnnn n
c i for nc n nn ci patients i with
ncn nn c i Hydradenitis
nc n n n c i Suppurativa
n c n n n nc i (HI)
nc n n n c i may
nc n n n n
c nc n n
i include
n c
A Clindamycin n
.
B Minocycline
n
.
C Metformin
n
, NRNP6552WomenshealthmidtermCorrectlyVerifiedQuestions n n n n
And Answers
n n
.
DAll of the n n
. above
Question 8 n 1/1
A There are too many studies involving women
n n n nn n n n n
.
B Most of the research is qualitative, which limits the applicability
.
C For many years, studies were done primarily on men with the findings
being
n
generalized to women
. n n n
D None of the above
n n n n
.
Question 9 1/1 n n
Most nc n n i malignancies
c nc n nn ci in i breast
nc n n c i tissue
nc n n n c i occur
nc n nn c i in:
nc n n c
A The areolar area
n n n
.
B The upper outer
n
n n nn
. quadrant
C The lower outer
n
n n n
. quadrant
D None of the above
n n n n
.
Question 10 n 0/1
On ivaginal i exam
nc n n n ncn nn c ncn nn c i you i find
ncnnn c ncnnn c i that i Polly’s
ncnnn c ncn nn c i cervix iis
nc n nn i in
ncnnn c ithe
nc n n n i most
ncnnn c i common
nc n n n c ncnn
i position,
n c i n c n n nn
which i is:
c ncn n n c
A Anterior n
.
B Midline
n
.
CPosterior
.
D Retroflex
n
. ed n